ReviewFrontiers in pharmacology2023

Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma.

Yumin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.